Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Sun Pharma enters licensing agreement with CMS for arthritis drug Tildrakizumab

      Sun Pharma enters licensing agreement with CMS for arthritis drug Tildrakizumab

      Medical Dialogues Bureau28 Jun 2019 12:30 PM IST
      The initial tenure of the agreement between Sun Pharma and CMS shall be 15 years from the first commercial sale of Tildrakizumab in Greater China and...
      Bayer contested Glyphosate use will eventually end, says German Chancellor

      Bayer contested Glyphosate use will eventually end, says German Chancellor

      Medical Dialogues Bureau28 Jun 2019 9:15 AM IST
      Bayer, which has been struggling to outrun the glyphosate crisis, two weeks ago announced it would spend 5 billion euros in researching alternative...
      Future of cheaper versions of biologic medicines in doubt

      Future of cheaper versions of biologic medicines in doubt

      Medical Dialogues Bureau28 Jun 2019 9:00 AM IST
      Biologic medicines treat cancer, rare diseases and autoimmune disorders like rheumatoid arthritis and colitis. Biosimilars are near-copies of them....
      GSK to fund doctoral programs at Government established Regional Centre for Biotechnology

      GSK to fund doctoral programs at Government established Regional Centre for Biotechnology

      Medical Dialogues Bureau27 Jun 2019 9:30 AM IST
      Under this initiative, the RCB will develop program content, manage logistics and oversee the running of the full-time programs while GSK...
      Historic ban of e-cigarette sales: San Francisco becomes first major US city to do so

      Historic ban of e-cigarette sales: San Francisco becomes first major US city to do so

      Medical Dialogues Bureau27 Jun 2019 9:15 AM IST
      The ordinance says e-cigarette products sold in shops or online in San Francisco would need approval by federal health authorities, which none...
      Swiss Government aims to legalise medical marijuana to treat cancer patients

      Swiss Government aims to legalise medical marijuana to treat cancer patients

      Medical Dialogues Bureau27 Jun 2019 9:00 AM IST
      "The proposal makes it possible for doctors to directly prescribe cannabis as part of their treatment," the Swiss cabinet said in a statement.ZURICH:...
      Bharat Biotech, Hilleman Labs collaborate to develop oral cholera vaccine HILLCHOL

      Bharat Biotech, Hilleman Labs collaborate to develop oral cholera vaccine HILLCHOL

      Medical Dialogues Bureau26 Jun 2019 4:42 PM IST
      New Delhi: Hyderabad-based vaccine maker, Bharat Biotech and Hilleman Laboratories today entered into a collaboration for further development,...
      Aurobindo Pharma, Dr Reddys, Torrent Pharma, Mylan cannot sell generic Gilenya patented by Novartis

      Aurobindo Pharma, Dr Reddys, Torrent Pharma, Mylan cannot sell generic Gilenya patented by Novartis

      Medical Dialogues Bureau26 Jun 2019 4:21 PM IST
      Novartis had asked for a preliminary injunction to halt generics makers including Dr Reddy's Laboratories (Dr Reddys), Mylan Pharmaceuticals, Torrent...
      Pfizer gets European nod for breast cancer treatment Talzenna

      Pfizer gets European nod for breast cancer treatment Talzenna

      Medical Dialogues Bureau26 Jun 2019 11:10 AM IST
      New Delhi: Drugmaker Pfizer Inc recently announced that the European Commission has approved TALZENNA (talazoparib) for BRCA-mutated advanced breast...
      Abbvie finalizes deal to buy Botox maker Allergan for $63 billion

      Abbvie finalizes deal to buy Botox maker Allergan for $63 billion

      Medical Dialogues Bureau26 Jun 2019 10:00 AM IST
      A note from Moody's affirmed Abbvie's debt rating, saying a plan to reduce debt through existing blockbusters like AbbVie's Humira and Imbruvica and...
      Bristol-Myers to sell blockbuster Otezla for its $74 billion merger with Celgene

      Bristol-Myers to sell blockbuster Otezla for its $74 billion merger with Celgene

      Medical Dialogues Bureau26 Jun 2019 9:00 AM IST
      Bristol-Myers announced its plans to buy Celgene in a cash-and-stock deal in early January to bring together the companies that specialize in oncology...
      Opioid use booming as tramadol crisis emerges in Africa- UN drug report

      Opioid use booming as tramadol crisis emerges in Africa- UN drug report

      Medical Dialogues Bureau26 Jun 2019 8:59 AM IST
      "Some consume tramadol for its calming, analgesic and anti-fatigue effects in order to improve intellectual, physical and working performances, and to...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok